REBECCA PATTON: Open Payments
NPI 1144289828 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 38 payments from 12 companies in 2025. Trend: 2023 $797 · 2024 $1,538 · 2025 $1,013
Food & beverage: $1,013
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $264 |
| Novartis Pharmaceuticals Corporation | 12 | $263 |
| GENZYME CORPORATION | 9 | $204 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $59 |
| Incyte Corporation | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| MERZ NORTH AMERICA, INC. | 1 | $27 |
| Amgen Inc. | 1 | $23 |
| Botanix SB Inc | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
Products named: TREMFYA, COSENTYX, DUPIXENT, ILUMYA, OPZELURA, Otezla, SOFDRA, SKYRIZI.
Industry payments across WA — which companies pay providers there.
